Danaher Corporation Depositary Receipt (DHR)
Market Closed
10 Aug, 20:00
AR$
6,080. 00
+115
+1.9279%
AR$
3.91B Market Cap
28.65 P/E Ratio
- Div Yield
883 Volume
7.58 Eps
AR$ 5,965
Previous Close Want to track DHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
DHR closed today higher at AR$6,080, an increase of 1.9279% from yesterday's close, completing a monthly increase of 7.9929% or AR$450. Over the past 12 months, DHR stock lost -8.0877%.
DHR is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on BCBA (ARS).
DHR Chart
People also search for
Danaher Corporation Depositary Receipt (DHR) FAQ
What is the stock price today?
The current price is AR$6,080.00.
On which exchange is it traded?
Danaher Corporation Depositary Receipt is listed on BCBA.
What is its stock symbol?
The ticker symbol is DHR.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 3.91B.
Has Danaher Corporation Depositary Receipt ever had a stock split?
No, there has never been a stock split.
Danaher Corporation Depositary Receipt Profile
| Professional Services Industry | Industrials Sector | Rainer Blair CEO | BCBA Exchange | - ISIN |
| US Country | 61,000 Employees | - Last Dividend | - Last Split | 5 Jan 1979 IPO Date |
Overview
Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.
Products and Services
- Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
- Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
- Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.
Contact Information
Address: 2200 Pennsylvania Avenue, NW
Phone: 202 828 0850
Website: https://www.danaher.com
